Noticias de Eulerpool Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB (publ) Noticias de Acciones

Swedish Orphan Biovitrum AB (publ) es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Swedish Orphan Biovitrum AB (publ).

• 12 de junio ·

  Yahoo
  Sobi share new clinical data across multiple hematologic diseases at EHA 2025
• 6 de junio ·

  Yahoo
  Sobi and Apellis: Aspaveli®/Empaveli® Demonstrates Sustained One-Year Efficacy in Phase 3 Study for Rare Kidney Diseases
• 6 de junio ·

  Yahoo
  Apellis and Sobi Announce EMPAVELI® (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN
• 4 de junio ·

  Yahoo
  Sobi Showcases Breadth of data in C3G/primary IC-MPGN at ERA 2025
• 3 de junio ·

  Yahoo
  Invitation: Sobi's Aspaveli® - 52-week Phase 3 VALIANT data in nephrology
• 28 de mayo ·

  Yahoo
  Sobi to share new clinical data and research at EULAR 2025
• 22 de mayo ·

  SeekingAlpha
  Swedish Orphan Biovitrum: Haematology Focus Seems To Be Paying Off
• 30 de abril ·

  Yahoo
  Swedish Orphan Biovitrum AB (BIOVF) Q1 2025 Earnings Call Highlights: Strong Haematology Growth ...
• 29 de abril ·

  SeekingAlpha
  Swedish Orphan Biovitrum AB (BIOVF) Q1 2025 Earnings Call Transcript
• 29 de abril ·

  Yahoo
  Sobi publishes Q1 2025 report: Portfolio continues to deliver